This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Injectable Drug Delivery To 2018 - Drugs, Devices, Targets, Therapeutics And Forecasts

NEW YORK, Feb. 25, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights• Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication• Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues• Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies• Forecasts Injectable drug product demand by indication and therapy to 2018• Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Summary of ContentsExecutive SummaryInjectable Drug Delivery Market DynamicsThe Injectable Drug EcosystemInjectable Drug Demand DriversDrug Development FactorsMarket FactorsTechnology FactorsCompetitive LandscapeAutoinjectorsNeedle-free InjectorsPen InjectorsPrefilled SyringesSafety Syringes Injectable Drug Demand DriversDiseases and IndicationsPatient DemographicsDeveloping Economies Risks and OpportunitiesInjectable Drug Device Selection CriteriaStability and Material Selection IssuesSingle vs Multi-Dose DevicesLyophilized Drugs/ReconstitutionSyringe Safety/Sharps ProtectionNeedle Configuration StrategiesDisposable Drug CartridgesHuman Engineering/ErgonomicsBranding/Private LabelingInjectable Drug Delivery – Device SegmentsAutoinjectorsAutoinjector-specific Selection FactorsPart Counts and Device Cost Safety Features Needle Shielding Needle Insertion Depth Failsafe Activation Dose Inspection/Injection ConfirmationAutoinjector Device Categories Reusable Autoinjectors Disposable Autoinjectors Product Specific Autoinjectors Drugs and Therapeutic SegmentsNeedle-free InjectorsDevice CategoriesEnd User/Practitioner/Mass Immunization InjectorsPrefilled Disposable ModelsRefillable Cartridge DesignsNeedle-free Injector-specific Selection FactorsEnergy SourceInjection Site SelectionPen InjectorsPen Injector Device CategoriesStandardized Pen PlatformsCustom Pen DesignsReusable PensPrefilled Pen CartridgesDisposable PensDual Chamber PensBranded Drug/Pen Injector Product by Therapeutic Segment Prefilled SyringesPrefilled Syringe Device CategoriesGlass Prefilled SyringesPrefillable Glass Syringe Manufacturers and Branded DevicesBranded Drug/Prefilled Glass Syringe Products by Therapeutic SegmentPlastic Prefilled SyringesBranded Prefillable Plastic SyringesDrugs and Therapeutic SegmentsPrefillable Safety SyringesPrefilled Syringe-specific Selection FactorsPFS Manufacturing FactorsFill-and-Finish OperationsSafety SyringesSafety Syringe Device CategoriesPrefillable Integrated Safety SyringesNon-Prefillable Integrated Safety SyringesRetractable NeedleManually RetractableAutomatic RetractableSliding SheathInjectable Drug Delivery – Therapeutic Segment Analysis & ForecastsAnaphylaxisAnticoagulantsAntiviralsAutoimmune DiseasesEmergency MedicineHematopoieticsHormone ReplacementMetabolic DiseasesNeurologyReproductive HealthVaccinesInjectable Drug Therapeutics - Market Factors Regulatory Factors and IssuesFDA RegulationsRegulating Combination Products Sharps LegislationsGrowth and Diversity of Safety SyringesSharps DisposalClinical Trial FactorsManaged Care and Healthcare Economics Company Profiles

To order this report: Drug_Delivery_Technology Industry: Injectable Drug Delivery to 2018 - Drugs, Devices, Targets, Therapeutics and Forecasts

__________________________Contact Clare: clare@reportlinker.comUS:(339) 368 6001Intl:+1 339 368 6001


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 0.00%
FB $117.81 0.00%
GOOG $701.43 0.00%
TSLA $211.53 0.00%
YHOO $36.94 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs